FIELD: medicine.
SUBSTANCE: group relates to peptides or polypeptides inducing the anti-alpha-synuclein antibody production in vivo for producing medicaments for preventing and/or treating synucleinopathies.
EFFECT: producing the peptides or polypeptides, which induce the antibodies responsible for the removal of the alpha-synuclein involved in the production of alpha-synuclein aggregates, the Lewy bodies, or for the dissolution of alpha-synuclein aggregates, the Lewy bodies in the individual suffering from synucleinopathies.
22 cl, 3 ex, 5 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| HUMANIZED IMMUNE BODIES IDENTIFYING ALPHA-SINUCLEIN | 2012 |
|
RU2575629C2 |
| COMPOUNDS FOR TREATMENT OF AMYLOIDOSIS | 2009 |
|
RU2491953C2 |
| ANTIBODIES AGAINST ALPHA SYNUCLEIN | 2018 |
|
RU2787039C2 |
| PROTOFIBRIL-BINDING ANTIBODIES AND USE THEREOF IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR PARKINSON'S DISEASE, DEMENTIA WITH LEWY BODIES AND OTHER ALPHA-SYNUCLEINOPATHIES | 2011 |
|
RU2555526C2 |
| HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEINE | 2012 |
|
RU2743738C2 |
| HUMANIZED ANTIBODIES, WHICH RECOGNIZE ALPHA-SINUCLEIN | 2013 |
|
RU2642262C2 |
| APPLICATION OF MIMOTOPES FOR TREATING BETA-AMYLOIDOSES | 2009 |
|
RU2553345C2 |
| PEPTIDE IMMUNOGENS FROM C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND COMPOSITIONS BASED ON THEM FOR TREATMENT OF SYNUCLEONOPATHIES | 2018 |
|
RU2810774C2 |
| ANTIBODIES TO ALPHA-SYNUCLEIN AND METHODS OF USING | 2014 |
|
RU2697098C1 |
| ANTIBODIES TO ALPHA-SYNUCLEIN AND METHODS OF USING | 2014 |
|
RU2718990C1 |
